This multiplex molecular panel identifies a wide range of respiratory pathogens including influenza A and B, respiratory syncytial virus, SARS-CoV-2, parainfluenza, adenovirus, human metapneumovirus, rhinovirus, certain coronaviruses, and bacteria like Mycoplasma pneumoniae and Bordetella pertussis. Identifying the specific cause supports targeted treatment and infection control.
This test is used in evaluation of respiratory infections, particularly in hospitalized patients, immunocompromised patients, and during outbreaks. Sample type is a nasopharyngeal swab or aspirate.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment